105
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Sensitizing effects of gallium citrate on hyperthermic cell killing in vitro

, , , , , & show all
Pages 457-470 | Published online: 09 Jul 2009

References

  • ADAMSON, R.H., CANELLOS, G.P., and SIEBER, S. M., 1975, Studies on the antitumor activity of gallium nitrate (NSC-15200) and other group Ma metal salts. Cancer Chemotherapy Report, 59, 599–610.
  • BORRELLI, M. J., RAUSCH, C. M., SEANER, R., and ILLmus, G., 1991, Sensitization to hyper-thermia by 3,3'-dipentyloxcarbocyanine iodide: a positive correlation with DNA damage and negative correlations with altered cell morphology, oxygen consumption inhibition, and reduced ATP levels. International Journal of Hyperthermia, 7, 243–261.
  • CHITAMBAR, C. R., and SELIGMAN, P. A., 1986, Effects of different transferrin forms on transferrin receptor expression, iron uptake and cellular proliferation of human leuke-mic HL60 cells. Journal of Clinical Investigation, 78, 1538–1546.
  • CHITAMBAR, C. R., and ZIVKOVIC, Z., 1987, Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-indepenolnt mechan-isms. Cancer Research, 47, 3929–3934.
  • CHITAMBAR, C.R, MATTHAEUS, W. G., ANTHOLINE, W. E., GRAFF, K., and O'BRIEN, W . J., 1988, Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribo-nucleotide reductase and demonstration of drug synergy with hydroxyurea. Blood, 72, 1930–1936.
  • EDWARDS, C. L., and HAYES, R. L., 1969, Tumor scanning with 67Ga citrate. Journal of Nuclear Medicine, 10, 103–105.
  • FOSTER, B. J., CLAGETT-CARR, K.,HOTH, D., and LEYLAND-JONES, B.,1986, Gallium nitrate: the second metal with clinical activity. Cancer Treatment Reports, 70, 1311–1319.FRONT, D., BAR-SHALOM, R., and ISRAEL, O., 1997, The continuing clinical role of gallium 67 scintigraphy in the age of receptor imaging. Seminar in Nuclear Medicine, 27, 68–74. GERWECK, L. E., 1985, Hyperthermia in cancer therapy: the biological basis and unresolved questions. Cancer Research, 45, 3408–3414.
  • HAHN, G. M., 1982, Hyperthermia and cancer (New York: Plenum).
  • HALL, E. J., 1988, Radiobiology for Radiobiologists, 3rd edn (Philadelphia: J. B. Lippincott CO.).
  • HAQ, R. U., WERELEY, J. P., and CHITAMBAR, C. R. 1995, Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells. Experimental Hematology, 23, 428–432.
  • HART, M. M., Small, C. F., YANCEY, S. T., and ADAMSON, R. H., 1971, Toxicity and anti-tumor activity of gallium nitrate and periodically related metal salts. Journal of The National Cancer Institute, 47, 1121–1127.
  • HUGHES, T. E., and HANSEN, L. A., 1992, Gallium nitrate. Annals of Pharmacotherapy, 26, 354–362.
  • HUIJGENS, P. C., JONKHOFF, A. R., HOEKSTRA, O. S., OSSENKOPPELE, G. J., and TEULE, G. J., 1993, Therapeutic potential of intravenous 67-gallium in non-Hodgkin's lym-phoma. European Journal of Haematology, 51, 206–208.
  • JONKHOFF, A. R.,HuuoENs,P. C VERSTEEGH, R. T., VAN LINGEN, A. OSSENKOPPELE, G. J., DRÄGER, A. M., and TEULE, G. J., 1995a, Radiotoxicity of 67-gallium on myeloid leukemic blasts. Leukemia Research, 19, 169–174.
  • JONKHOFF, A. R., PLAIZIER, M. A. B. D OSSENKOPPELE, G. J., TEULE, G. J., and HUIJGENS, P. C., 1995b, High-dose gallium-67 therapy in patients with relapsed acute leukaemia: a feasibility study. British Journal of Cancer, 72, 1541–1546.
  • KAPLAN, W. D., JOCHELSON, M. S., HERMAN, T. S., NADLER, L. M., STOMPER, P. C., TAKVORIAN, T., AND SERSEN, J. W., and CANELLOS, G. P., 1990, Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. Journal of Clinical Oncology, 8, 1966–1970.
  • KRISHNA, M. C., DEWHIRST, M. W., FRIEDMAN, H. S., COOK, J. A., DEGRAFF, W SAMUNI, A., Russo, A., and MITCHELL, J. B., 1994, Hyperthermic sensitization by the radical initiator 2,21-azobis(2-amidinopropane) dihydrochloride (AAPH). 1. in vitro studies. International Journal of Hyperthermia, 10, 271–281.
  • LARSON, S. M., RASEY, J. S., ALLEN, D. R., NELSON, N. J., GRAUNBAUM, Z., HARP, G. D., and WILLIAMS, D.L.,1980, Common pathway for tumor cell uptake of gallium-67 and iron-59 via a transferrin receptor. Journal of The National Cancer Institute, 64, 41–53.
  • LUNEC, J., and CRFSSWEL, S. R 1983, Heat-induced thermotolerance expressed in the energy metabolism of mammalian cells. Radiation Research, 93, 588–597.
  • MALFETANO, J. H., BLESSING, J. A., and HOMESLEY, H. D., 1995, A Phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carvinoma of the cervix. A Gynecologic Oncology Group study. American Journal of Clinical Oncology, 18, 495–497.
  • NARSIMHAN, J., ANTHOLINE, W. E., and CHITAMBAR, C. R., 1992, Effect of gallium on the tyrosyl radical of the iron-dependent M2 subunit of ribonucleotide reductase. Biochemical Pharmacology, 44, 2403–2408.
  • RASEY, J. S., NELSON, N. J., and LARSON, S. M., 1982, Tumor cell toxicity of stable gallium nitrate: enhancement by transferrin and protection by iron. European Journal of Cancer and Clinical Oncology, 18, 661–668.
  • SEIDMAN, A. D., SCHER, H. I., HEINEMANN, M. H., BAJORIN, D. F., STERNBERG, C. N., DERSHAW,D D. D., SILVERBERG, M., and BOSL, G. J., 1991, Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors. Cancer, 68, 2561–2565.
  • SHINOHARA, K., KAWAKAMI, N., Pro, A., KUGOTANI, M., NAKANO, H. ISHIWATA, J., and MATSUDA, T., 1993, The role of ATP metabolism in hyperthermic cell killing. Cancer treatment by hyperthermia, radiation and drugs, edited by T. Matsuda (London: Taylor & Francis), pp. 79–91.
  • SHINOHARA, K., KAWAKAMI, N., KUGOTANI, M., and NAKANO, H., 1988, Gallium citrate, a new sensitizer of cells to hyperthermia. Japanese Journal of Cancer Research, 79, 21–23.
  • SHINOHARA, K., KUGOTANI, M., ISHIWATA, J., and MATSUDA, T., 1987, Early changes of adenosine triphosphate levels in L5178Y cells during hyperthermia. Japanese Journal of Cancer Research, 78, 333–335.
  • TSAN, M. F., and SCHEFFEL, U., 1986, Mechanism of gallium-67 accumulation in tumors. Journal of Nuclear Medicine, 27, 1215–1219.
  • VALLABHAJOSULA, S. R., HARWIG, J. F SIEMSEN, J. K., and WOLF, W., 1980, Radiogallium localization in tumors: blood binding and transport and the role of transferrin. Journal of Nuclear Medicine, 21, 650–656.
  • VAN LEEUWEN-STOK, A. E., DRÄGER, A. M., SCHUURHUIS, G. J., PLATIER, A. W. J., TEULE, G. J. J., and HUIJGENS, P. C., 1993, Gallium-67 in the human lymphoid cell line U-715: uptake, cxytotoxicity, and intracellular localization. International Journal of Radiation Biology, 64, 749–759.
  • WARRELL, R. P. JR., BOCKMAN, R. S., COONLEY, C. J., IsAAcs, M., and STASZEWSKI, H., 1984, Gallium nitrate inhibits calcium resorption from bone and its effective treatment for cancer-related hypercalcemia. Journal of Clinical Investigation, 73, 1487–1490.
  • WARRELL, R. P. JR., COONLEY, C. J., STRAUS, D. J., and YOUNG, C. W., 1983, Treatment of patients with advanced malignant lymphoma using gallium nitrate adminstered as a seven-day continuous infusion. Cancer, 51, 1982–1987.
  • WEINER, R. E., 1996, The mechanism of 67Ga localization in malignant disease. Nuclear Medicine & Biology, 23, 745–751.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.